ROCKET PHARMACEUTICALS, INC. short interest in 2022
In 2022, ROCKET PHARMACEUTICALS, INC.'s disclosed short interest ran from 13.35% of shares outstanding on 14 Jan 2022 to 9.30% on 30 Dec 2022, a change of -4.05 percentage points. The year's high was 17.80% on 15 Sep 2022 and its low 9.29% on 15 Dec 2022, averaging 13.06% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.03 days on 14 Apr 2022. Full history: ROCKET PHARMACEUTICALS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 13.35% (14 Jan 2022)
- End of year
- 9.30% (30 Dec 2022)
- Change
- -4.05 pp
- High
- 17.80% (15 Sep 2022)
- Low
- 9.29% (15 Dec 2022)
- Average
- 13.06%
- Highest days to cover
- 25.03 (14 Apr 2022)
- SEC filings marked
- 7
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 13.35% | 15.44 | |
| 31 Jan 2022 | 12.13% | 15.72 | |
| 15 Feb 2022 | 12.68% | 14.84 | |
| 28 Feb 2022 | 12.83% | 20.26 | results (8-K), 10-K filed |
| 15 Mar 2022 | 13.09% | 15.53 | |
| 31 Mar 2022 | 13.60% | 24.75 | |
| 14 Apr 2022 | 13.42% | 25.03 | |
| 29 Apr 2022 | 11.73% | 12.37 | |
| 13 May 2022 | 11.45% | 8.56 | 10-Q filed |
| 31 May 2022 | 12.61% | 7.51 | |
| 15 Jun 2022 | 12.03% | 9.03 | |
| 30 Jun 2022 | 12.54% | 8.24 | |
| 15 Jul 2022 | 13.04% | 9.48 | |
| 29 Jul 2022 | 13.71% | 13.01 | |
| 15 Aug 2022 | 16.26% | 14.75 | results (8-K), 10-Q filed |
| 31 Aug 2022 | 16.45% | 18.95 | |
| 15 Sep 2022 | 17.80% | 10.53 | |
| 30 Sep 2022 | 17.11% | 7.86 | |
| 14 Oct 2022 | 14.32% | 7.55 | |
| 31 Oct 2022 | 14.24% | 12.48 | |
| 15 Nov 2022 | 10.32% | 9.42 | results (8-K), 10-Q filed |
| 30 Nov 2022 | 10.08% | 11.29 | |
| 15 Dec 2022 | 9.29% | 7.50 | |
| 30 Dec 2022 | 9.30% | 4.81 |
See also: ROCKET PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.